For a complete timeline of retatrutide's clinical development, see Retatrutide Clinical Trial Timeline: The Complete TRIUMPH Program Guide
Particular attention is needed for potential effects on pancreatic safety, including pancreatitis and pancreatic cancer risk
Clinical studies indicate that appetite and weight changes tend to be the most consistently reported effects after stopping GLP-1 medications, while the other symptoms listed above vary more widely from person to person
Foods that help maintain satiety include lean meats, eggs, Greek yogurt, beans and lentils, vegetables, and whole grains
This suggests inherent stability in acidic environments that many other peptides lack, according to preclinical findings
The cagrilintide and semaglutide combination (known as CagriSema) is being studied as a next-generation obesity treatment